Back to Blog

The Omega-3 Index: The Blood Test That Predicts Heart Disease Risk

February 19, 2026·5 min read

Most people who take fish oil supplements have no idea whether their supplement is working. Capsule dosage does not equal absorbed omega-3s, and absorption varies dramatically between individuals, products, and meals. The omega-3 index is the test that closes that gap — and it turns out to predict heart disease risk as strongly as LDL cholesterol.

What the Omega-3 Index Measures

The omega-3 index is defined as EPA (eicosapentaenoic acid) plus DHA (docosahexaenoic acid) expressed as a percentage of total fatty acids in red blood cell membranes. Because red blood cells live roughly 90-120 days, the index reflects your average omega-3 status over that period — similar in concept to HbA1c for glucose.

This is fundamentally different from measuring omega-3s in plasma or serum, which reflects only recent intake (what you ate in the last few days) and fluctuates widely. The red blood cell measurement captures stable, integrated tissue status.

Risk Stratification

The omega-3 index risk categories were established by researchers William Harris and Clemens von Schacky, who developed the test:

  • Below 4%: High cardiovascular risk zone
  • 4-8%: Intermediate risk zone
  • Above 8%: Low cardiovascular risk zone
  • Optimal target: 8-12% for most people seeking maximum benefit

In the MESA study (Multi-Ethnic Study of Atherosclerosis), individuals in the highest omega-3 index quartile had a 39% lower risk of fatal coronary heart disease compared to the lowest quartile. The Framingham Heart Study found that low omega-3 index was associated with accelerated brain aging equivalent to approximately two years of structural brain loss.

The average American has an omega-3 index of approximately 4-5% — squarely in the intermediate risk zone. Most Western European countries average 6-7%; Japan, with its high fish intake, averages 8-10%.

How to Get Tested

OmegaQuant (omegaquant.com) is the primary direct-to-consumer testing laboratory for omega-3 index measurement. The test uses a finger-stick blood spot collected at home, mailed on a dried blood card. Cost is approximately $65-90 for the omega-3 index alone; expanded panels adding vitamin D, HbA1c, and other markers run $100-150.

Results are returned within 2-3 weeks. OmegaQuant's methodology is used in the majority of published omega-3 index research, making their reference ranges directly applicable.

Some physician-ordered lipid panels now include omega-3 index (Quest Diagnostics offers it), but it must be specifically requested and may require prior authorization.

Why Serum Omega-3 Tests Are Less Useful

Several companies offer omega-3 testing from serum or plasma rather than red blood cells. These tests have a fundamentally different meaning: serum omega-3 levels reflect recent intake, not tissue status. If you ate fatty fish the night before your blood draw, your serum omega-3 levels will be high regardless of your baseline status. If you fasted or skipped your supplement, they will be low.

For tracking whether supplementation is working and estimating cardiovascular risk, only the red blood cell-based index provides meaningful longitudinal data.

How Supplements Affect the Index

The omega-3 index takes 3-4 months to reach a new steady state after changing intake — matching the lifespan of red blood cells. Do not retest sooner than 3 months after starting or adjusting supplementation.

Key variables that affect how much a given supplement dose raises your index:

  • Baseline level: People starting at 4% see larger absolute gains than those starting at 7%
  • Supplement form: Triglyceride-form fish oil is absorbed 25-70% better than ethyl ester form (check the supplement facts label)
  • Taken with fat: Omega-3s require dietary fat for optimal absorption — take with a meal
  • Product EPA+DHA content: A "1,000 mg fish oil" capsule may contain only 300 mg combined EPA+DHA

To move from a typical American baseline of 5% to the target of 8%, most people need 2-3g of combined EPA+DHA daily from a quality triglyceride-form fish oil, taken with meals.

Diet vs. Supplement Sources

Fatty fish (salmon, mackerel, sardines, herring, anchovies) are the most efficient dietary sources. Two 3.5-ounce servings of fatty fish per week provides roughly 1-1.5g EPA+DHA — enough to maintain a moderate index but often insufficient to raise a low one to optimal. For people starting below 4% or aiming for 10%+, supplementation is generally necessary to reach the target efficiently.

Algae-based omega-3s (derived from the microalgae that fish eat) are an effective vegan alternative providing DHA and EPA in triglyceride form. Flaxseed and other ALA-containing plants convert inefficiently to EPA and DHA in humans — conversion rates are typically under 5-10% for EPA and under 1% for DHA, making them insufficient for raising the omega-3 index meaningfully.

Optimal Target and Monitoring

Most researchers consider 8-12% the optimal range for cardiovascular and cognitive benefit. Athletes and people with inflammatory conditions may benefit from the higher end. Once you reach your target, retesting every 12-18 months is sufficient to confirm you are maintaining it.

The bottom line

The omega-3 index is a 90-day snapshot of cardiovascular and cognitive risk that responds directly to diet and supplementation — and most people who take fish oil have never confirmed it is working.


Find out if your omega-3 intake is actually moving the needle, and build a supplement protocol matched to your results. Use Optimize free.

Related Articles

Want to optimize your health?

Create your free account and start tracking what matters.

Sign Up Free